X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (325) 325
conjunctival diseases - chemically induced (237) 237
male (230) 230
ophthalmology (217) 217
female (192) 192
adult (145) 145
middle aged (145) 145
index medicus (128) 128
aged (117) 117
conjunctival diseases - pathology (68) 68
animals (67) 67
corneal diseases - chemically induced (55) 55
glaucoma (52) 52
eye burns - chemically induced (51) 51
hyperemia - chemically induced (48) 48
administration, topical (43) 43
aged, 80 and over (43) 43
conjunctiva - drug effects (43) 43
conjunctiva - pathology (42) 42
adolescent (40) 40
intraocular pressure - drug effects (40) 40
treatment outcome (38) 38
ophthalmic solutions (36) 36
conjunctiva (35) 35
antihypertensive agents - adverse effects (34) 34
conjunctival diseases - diagnosis (34) 34
prospective studies (34) 34
benzalkonium chloride (31) 31
child (31) 31
glaucoma - drug therapy (31) 31
rabbits (31) 31
burns, chemical - surgery (29) 29
eye diseases - chemically induced (29) 29
follow-up studies (29) 29
glaucoma, open-angle - drug therapy (28) 28
ocular surface (28) 28
retrospective studies (28) 28
eye diseases (27) 27
eyelid diseases - chemically induced (27) 27
visual acuity (27) 27
latanoprost (26) 26
conjunctival diseases - drug therapy (25) 25
ocular hypertension - drug therapy (24) 24
ophthalmic solutions - adverse effects (24) 24
preservatives, pharmaceutical - adverse effects (24) 24
surgery (24) 24
eye (23) 23
time factors (23) 23
corneal diseases - surgery (22) 22
conjunctival diseases - surgery (21) 21
amniotic membrane transplantation (20) 20
injections (20) 20
open-angle glaucoma (20) 20
risk factors (20) 20
care and treatment (19) 19
young adult (19) 19
corneal diseases - pathology (18) 18
disease models, animal (18) 18
edema - chemically induced (18) 18
eye burns - surgery (18) 18
ocular hypertension (18) 18
prostaglandins f, synthetic - adverse effects (18) 18
therapy (18) 18
child, preschool (17) 17
drug therapy, combination (17) 17
eye hemorrhage - chemically induced (17) 17
in-vitro (17) 17
medicine & public health (17) 17
sense organs (17) 17
conjunctival diseases - prevention & control (16) 16
dry eye (16) 16
prevalence (16) 16
antihypertensive agents - therapeutic use (15) 15
cloprostenol - analogs & derivatives (15) 15
dose-response relationship, drug (15) 15
double-blind method (15) 15
dry eye syndromes - chemically induced (15) 15
pharmacology & pharmacy (15) 15
pigmentation disorders - chemically induced (15) 15
prostaglandins f, synthetic - therapeutic use (15) 15
timolol (15) 15
transplantation, autologous (15) 15
bimatoprost (14) 14
complications and side effects (14) 14
conjunctival diseases - etiology (14) 14
cornea - drug effects (14) 14
limbus corneae - cytology (14) 14
mitomycin - adverse effects (14) 14
ophthalmic solutions - administration & dosage (14) 14
prostaglandins f, synthetic - administration & dosage (14) 14
research (14) 14
stem cell transplantation (14) 14
travoprost (14) 14
anti-bacterial agents - adverse effects (13) 13
antihypertensive agents - administration & dosage (13) 13
benzalkonium compounds - adverse effects (13) 13
conjunctival (13) 13
conjunctival hyperemia (13) 13
cornea (13) 13
corneal (13) 13
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (335) 335
French (13) 13
German (10) 10
Chinese (7) 7
Spanish (6) 6
Russian (4) 4
Polish (3) 3
Romanian (2) 2
Czech (1) 1
Japanese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Hematology, ISSN 0939-5555, 9/2012, Volume 91, Issue 9, pp. 1393 - 1401
In the present study, we evaluated the ophthalmologic outcomes of 24 patients who received chemotherapy and/or radiotherapy for the treatment of... 
Chemotherapy | Medicine & Public Health | Hematology | Oncology | Non-conjunctival MALT lymphoma | Ophthalmologic outcomes | Radiotherapy | 1ST-LINE TREATMENT | MALIGNANT-LYMPHOMA | MARGINAL ZONE | RADIATION-THERAPY | B-CELL LYMPHOMA | ORBIT | PROGNOSTIC-SIGNIFICANCE | CLINICAL BEHAVIOR | LYMPHOPROLIFERATIVE DISORDERS | HEMATOLOGY | TISSUE-TYPE | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Cataract - chemically induced | Humans | Middle Aged | Retinal Diseases - chemically induced | Male | Lacrimal Apparatus Diseases - therapy | Radiotherapy - adverse effects | Chemoradiotherapy | Cyclophosphamide - adverse effects | Retinal Diseases - epidemiology | Eye Neoplasms - drug therapy | Radiotherapy, Adjuvant - adverse effects | Retinal Diseases - etiology | Aged, 80 and over | Ocular Hypertension - chemically induced | Vincristine - administration & dosage | Ocular Hypertension - epidemiology | Prednisone - adverse effects | Rituximab | Orbital Neoplasms - drug therapy | Combined Modality Therapy | Blepharitis - chemically induced | Vincristine - therapeutic use | Vincristine - adverse effects | Xerophthalmia - epidemiology | Antibodies, Monoclonal, Murine-Derived - adverse effects | Optic Nerve Diseases - epidemiology | Optic Nerve Diseases - etiology | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Eye Neoplasms - radiotherapy | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Blepharitis - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lymphoma, B-Cell, Marginal Zone - therapy | Cataract - epidemiology | Eye Neoplasms - therapy | Cyclophosphamide - therapeutic use | Blepharitis - etiology | Orbital Neoplasms - therapy | Lacrimal Apparatus Diseases - drug therapy | Female | Xerophthalmia - etiology | Retrospective Studies | Orbital Neoplasms - radiotherapy | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Optic Nerve Diseases - chemically induced | Cataract - etiology | Treatment Outcome | Lacrimal Apparatus Diseases - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Aged | Ocular Hypertension - etiology | Xerophthalmia - chemically induced | Doxorubicin - adverse effects
Journal Article
Journal Article
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 05/2010, Volume 88, Issue 3, pp. 329 - 336
. Purpose:  The purpose of this study was to investigate the tolerability and intraocular pressure (IOP) reducing effect of the first preservative‐free... 
patient satisfaction | preservative‐free tafluprost ophthalmic solution | Taflotan | tolerability | Xalatan® latanoprost | IOP | quality of life | latanoprost | Preservative-free tafluprost ophthalmic solution | Xalatan | Tolerability | Patient satisfaction | Quality of life | LATANOPROST | SIGNS | Taflotan (R) | Xalatan (R) latanoprost | PHARMACODYNAMICS | OCULAR SYMPTOMS | TAFLUPROST | preservative-free tafluprost ophthalmic solution | OPHTHALMOLOGY | RECEPTOR AGONIST | Hyperemia - metabolism | Intraocular Pressure - drug effects | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Hyperemia - prevention & control | Conjunctival Diseases - metabolism | Ocular Hypertension - drug therapy | Patient Satisfaction | Prostaglandins F, Synthetic - administration & dosage | Aged, 80 and over | Tonometry, Ocular | Adult | Female | Surveys and Questionnaires | Conjunctival Diseases - chemically induced | HLA-DR Antigens - metabolism | Conjunctival Diseases - prevention & control | Preservatives, Pharmaceutical - adverse effects | Prostaglandins F - administration & dosage | Benzalkonium Compounds - adverse effects | Ophthalmoscopy | Benzalkonium Compounds - administration & dosage | Prostaglandins F, Synthetic - adverse effects | Blepharitis - metabolism | Glaucoma, Open-Angle - drug therapy | Blepharitis - prevention & control | Blepharitis - chemically induced | Exfoliation Syndrome - drug therapy | Mucin 5AC - metabolism | Quality of Life | Hyperemia - chemically induced | Aged | Gonioscopy | Preservatives, Pharmaceutical - administration & dosage | Administration, Topical | Glaucoma | Prostaglandins | Analysis | Pharmacy | Ophthalmic drugs | Mucins | Fluorescein | Ophthalmology | Universities and colleges | Drug therapy
Journal Article
Clinical & Experimental Ophthalmology, ISSN 1442-6404, 09/2012, Volume 40, Issue 7, pp. 675 - 681
Journal Article